Trials / Completed
CompletedNCT02295813
Safety and Pharmacokinetics Study of FBF001
A Single Center, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Pharmacokinetics of One Single Intravenous Dose and 5-day Repeated Intravenous Doses of FBF001 in Healthy Male Subjects
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 16 (actual)
- Sponsor
- Fab'entech · Industry
- Sex
- Male
- Age
- 21 Years – 40 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to assess the clinical and laboratory safety and to determine the pharmacokinetic profile of FBF001.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | FBF001 | |
| DRUG | Placebo |
Timeline
- Start date
- 2012-10-01
- Primary completion
- 2012-12-01
- First posted
- 2014-11-20
- Last updated
- 2014-11-20
Source: ClinicalTrials.gov record NCT02295813. Inclusion in this directory is not an endorsement.